Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited

It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2008-2009. During the financial year, The Company’s Consolidated revenues increased by 39% to Rs. 69,441 million, or U.S.$. 1.37 billion in 2008-09 from Rs. 50,006 million in 2007-08. Gross profit increased by 44% to Rs. 36,500 million in 2008-09. EBIDTA stood at Rs. 14,529 million in 2008-09, compared to Rs. 9,661 million in 2007-08, showing a growth of 50%. Net loss of Rs. 5,168 million in 2008-09 as against net profit of Rs. 3,836 million in 2007-08. During the year net income increased by 44% to Rs. 8,855 million in 2008-09 from Rs. 6,937 million in 2007-08. The Company’s fully diluted earnings per share decreased to (Rs. 30.69) in 2008-09 from Rs. 22.80 in 2007-08.

The Board of Directors of the Company has proposed a dividend of Rs. 6.25 per share (125%) on equity shares of Rs. 5/- each. The dividend will be paid on or after 26^th July 2009, if declared by the shareholders at the Annual General Meeting scheduled on 22^nd July 2009.

More Annual Report of Dr. Reddy’s Laboratories Limited: